Cipla

BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | SECTOR: Biotechnology & Drugs

1,423.15

-1.60 (-0.11%)
06 May 2024, 03:12 PM IST

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

51,410.371,410.20
101,385.641,385.55
201,422.291,422.67
501,448.271,448.41
1001,372.891,373.08
3001,280.901,281.09

News

Company Description

Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.

Company Officers